Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network

Author： Herrera Alex F.   Crosby-Thompson Allison   Friedberg Jonathan W.   Abel Gregory A.   Czuczman Myron S.   Gordon Leo I.   Kaminski Mark S.   Millenson Michael M.   Nademanee Auayporn P.   Niland Joyce C.   Rodig Scott J.   Rodriguez Maria A.   Zelenetz Andrew D.   LaCasce Ann S.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|13|1993-1999

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.13, 2014-07, pp. : 1993-1999

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Infliximab linked to T-cell lymphoma in young patients

By  

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Panobinostat is promising for the treatment of patients with cutaneous T-cell lymphoma

By  

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Dismal outcome of t‐cell lymphoma patients failing first‐line treatment: results of a population‐based study from the Modena Cancer Registry

By  

Hematological Oncology (Electronic), Vol. 33, Iss. 3, 2015-09 ,pp. : 147-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dismal outcome of t‐cell lymphoma patients failing first‐line treatment: results of a population‐based study from the Modena Cancer Registry

By  

Hematological Oncology (Electronic), Vol. 278-0232, Iss. 3, 2015-09 ,pp. : 147-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Alemtuzumab/fludarabine: EBV-associated B-cell lymphoma in patients with peripheral T-cell lymphoma: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1236, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite